Ireland
Founded in 2016 and headquartered in Ireland, CroiValve is an innovative early-stage medical device company focused on addressing heart valve disease. With its slogan, "Treating Heart Valve Disease," the company is dedicated to developing a unique transcatheter device designed specifically to repair the tricuspid valve.
CroiValve is committed to improving cardiovascular health and offers a promising solution to an unmet medical need. Despite being at an early stage, the company has demonstrated potential within the rapidly growing market for heart valve interventions. The medical device that CroiValve is developing aims to provide less invasive, more effective treatment options, potentially reducing the need for open-heart surgery.
The company's recent financial milestone was a Series B investment secured on 07 August 2024. While specific investor names and investment amounts were not disclosed, this injection of funds signifies strong investor confidence in CroiValve's vision and technological capabilities.
